The key to effective and lasting quality improvement is better, not more, regulation.
Professor Alan Maynard, University of York, delivered the 20th OHE Annual Lecture five months after release of the Francis Report, a public inquiry into serious failures in patient care at the Mid Staffordshire NHS Foundation Trust.
This study finds an apparent mismatch in the decision making approaches of the SMC and the NHS Boards.
OHE today released a Research Paper on the use of QALY thresholds in NHS Scotland for health services that were "at the margin” in 2012–13, i.e. those for which investment or disinvestment was planned or occurred. The study was based on information from three sources.
This respected compilation contains data on demographics, expenditures, hospitals and workforce, and health services.
For nearly 40 years the OHE has been a specialist provider of data analytics to the health care and pharmaceutical sectors. The latest edition of the OHE Guide to UK Health and Health Care Statistics is now available online, providing both reliable statistics and a basic guide to their use.
This research varies from other analyses in using a product-level, rather than a macro, approach.
PharmacoEconomics has just published OHE’s study projecting medicines expenditure in the UK to 2015. ( The methodology for this research varies from earlier approaches in using a product-level, or “bottom-up”, approach, rather than a top-down, macro perspective.
Four papers presented at the EuroQol Plenary discussed preliminary findings.
As reported earlier, OHE’s Prof Nancy Devlin and Prof Ben van Hout of the University of Sheffield were awarded a £457,000 grant from the Policy Research Programme (PRP) of the UK’s National Institute for Health Research (NIHR) for research on an EQ-5D-5L value set for England.
At an OHE seminar last week, Dr James Chambers of Tufts Medical School examined the role cost-effectiveness evidence plays in health care resource allocation in the US and the potential value of expanding that.
Following allegations of seriously substandard care, the Secretary of State for Health in England announced, in June 2010, that a public inquiry into the Mid Staffordshire NHS Foundation Trust would be undertaken, chaired by Robert Francis QC (a lawyer). The “Francis report”, issued in February 2013, contains 290 recommendations meant to apply across the NHS. This, in turn, has given rise to heated debates about quality in the NHS and how best to ensure it.
Professor Adrian Towse, OHE’s Director, joined Professor Sir John Bell and Professor Andrew Morris at the Science Media Centre last week to launch Realising the Potential of Stratified Medicine, a new report by the UK’s Academy of Medical Sciences. Adrian and Professor Lou Garrison, OHE Visiting Senior Research Fellow, were two of a dozen experts who oversaw the preparation of the report.
A new publication from the Office of Health Economics captures the views of thought leaders from around the world about the scientific and economic climate for drug development by 2022. Based on OHE’s 50th anniversary conference, it reflects the perspectives of payers, regulatory and HTA agencies, academia, the non-profit sector and the biopharmaceutical industry.